Site logo

"Жизнь коротка, наука -- бесконечна" (Гиппократ)
Новое в науке на 2026-09-01

A single-amino-acid cleavage controls global mitochondrial complex integrity

Kücükköse, Luzarowski and colleagues show that removing a single N-terminal amino acid during the maturation of newly imported mitochondrial proteins globally stabilizes mitochondrial protein complexes, revealing an unexpected layer of regulation of mitochondrial proteostasis.

2026-08-31

l-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial

In this open-label, single-arm, phase 1 GlutaPanc trial, Gong and colleagues report the safety and feasibility of l-glutamine in participants with advanced pancreatic ductal adenocarcinoma and determine the recommended phase 2 dose of l-glutamine in combination with gemcitabine and nab-paclitaxel.

2026-08-31

Structural and mechanistic insights into gating and allosteric modulation of GluN1–GluN3A NMDA receptors

Kim et al. present cryo-EM structures of GluN1–GluN3A NMDA receptors with complementary electrophysiology, revealing structure-based mechanisms of receptor gating, paradoxical potentiation by a GluN1-selective antagonist and allosteric modulation.

2026-08-28

Dissecting pleiotropy between major depressive disorder and physical disease comorbidities

This study uses genomic structural equation modeling to analyze genetic relationships between major depressive disorder and physical disease comorbidities and identifies independent loci associated with their shared genetic liability.

2026-08-26

Predictive design of tissue-specific mammalian enhancers that function in the mouse embryo

Researchers used AI to design synthetic transcriptional enhancers that are active in specific tissues in mammals and validated their function in mice. This type of approach could enable advanced gene expression control in synthetic biology and gene therapy.

2026-08-25

Galanin impairs tumor immunity in glioblastoma by promoting infiltration and ferroptosis resistance of myeloid-derived suppressor cells

Chen and colleagues report that the neuropeptide galanin impairs antitumor immunity in glioblastoma by interacting with its receptor GALR3 on monocytic myeloid-derived suppressor cells, promoting their infiltration and ferroptosis resistance.

2026-08-25

Giant Sunflower Genomes Advance the Case for Climate-Resilient Perennial Crops

Researchers at the Land Institute and the HudsonAlpha Institute for Biotechnology have produced the first chromosome-scale, haplotype-phased genome...

2026-08-24

Genomic Map Reveals How Animal Chromosomes Evolve Along Fixed Paths

A study (https://www.science.org/doi/10.1126/sciadv.adz5561) published in Science Advances by researchers at the University of Vienna maps how genome...

2026-08-20

New Tool Estimates Cellular Age from Gene Activity Patterns

Aging is a major risk factor for many diseases, but reliable methods for measuring how quickly cells age have been lacking. Now, researchers at...

2026-08-18

DNA Repair Enzymes Favor Specific Genome Sequences, Study Finds

An unhealed wound leaves a scar. In the genome, an unrepaired DNA lesion leaves a mutation — a permanent edit to the genetic code. Mutations can...

2026-08-13

Single-Cell Atlas Pinpoints Spinal Neurons Controlling Movement Speed

Scientists at St. Jude Children’s Research Hospital have built a single-cell atlas of V1 interneurons, a key class of spinal neurons involved in...

2026-08-11